| |
|
|
|
Evoke Pharma  
|
|
1.09 -0.02 (-0.02%) |
09-16 16:00 |
|
Open: |
1.09 |
Pre close: |
1.11 |
Target:
|
1.57
|
|
High: |
1.12 |
Low: |
1.07 |
Resistance:
|
1.34
1.58
|
|
Volume: |
84,704 |
Market Cap: |
35M |
Support:
|
0.96
0.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.11
 |
MACD |
MACD(12,26):
|
-0.02  |
|
MA(20): |
1.10 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.26 |
Stochastic Oscillator |
%K(14,3):
|
30.06 |
|
MA(250): |
2.37 |
%D(3): |
40.87 |
|
Average Volume(K) |
3-Month: |
4582065
|
52-Week |
High:
|
5.00 |
|
10-Days: |
254629 |
Low: |
0.96 |
|
RSI |
RSI(14):
|
45.81 |
Change(%): |
-77.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.514 |
Return on Equity (ttm) |
-260.3 |
Shares Out. (M) |
32.37 |
|
EPS Est. Current Year |
-0.820 |
Return on Assets (ttm) |
-72.3 |
Shares Float (M) |
29.68 |
|
EPS Est. Next Year |
-0.170 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.05 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.05 |
|
Forward EPS |
-0.320 |
Gross Profit (p.s.) |
-0.002 |
Shares Short (K) |
988 |
|
Book Value (p.s.) |
0.240 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.12 |
|
Sales Per Share |
0.004 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.54 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.03 |
P/S |
311.03 |
|
Operating Margin |
-12203.80 |
Levered Free Cash Flow
(M) |
-2.99 |
P/CF |
-4.39 |
|
|
|
|
|
|
